NIH chief says comparative studies hold risk for personalized medicine

10/26/2009 | Reuters

The use of comparative-effectiveness research as a means to reduce health care costs could jeopardize the advances in personalized medicine because such studies tend to miss groups of people who might benefit from a particular treatment, NIH Director Dr. Francis Collins said. "We need to be mindful of the goal of comparative-effectiveness research and not lose all that we have gained in understanding how individuals differ and how that could be factored into better diagnostics and preventive strategies," Collins said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX